ifenprodil and sorafenib

ifenprodil has been researched along with sorafenib in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chan, BKC; Cheung, MSH; Choi, GCG; Chu, HY; Fong, JHC; Huang, Y; Ma, S; Mak, KH; Pardeshi, L; Tong, CSW; Tong, M; Wong, ASL; Wong, KH; Wong, TL; Xu, F1

Other Studies

1 other study(ies) available for ifenprodil and sorafenib

ArticleYear
A Combinatorial CRISPR-Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment.
    Cancer research, 2021, 12-15, Volume: 81, Issue:24

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Proliferation; CRISPR-Cas Systems; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Piperidines; Sorafenib; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2021